Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-29

Clinical Trial Update: Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of Vitamin D3 on musculoskeletal symptoms in patients taking aromatase inhibitors; results completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aromatase inhibitors (aromatase inhibitor)
  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: HealthPartners Institute | Conditions: Muscle Pain, Joint Pain | Phase 2 | Status: COMPLETED | Results posted: 2016-11-29